A case of a malignant pancreatic polypeptide secreting tumour is reported. The tumour was metastatic at presentation at which time it was excised. Pancreatic duct obstruction occurred 3 years after excision causing severe pain on eating. Major palliative surgery, in the form of a pancreatico-jejunostomy, cured the severe symptoms. The patient survives, largely symptom free, over six years after original excision. This case illustrates the need for aggressive management of symptoms in tumours in which long term survival is possible despite locally advanced or metastatic disease. ABBREVIATIONS: VIP vasoactive intestinal peptide. CT computed tomography. GI gastrointestinal. HPP-human pancreatic polypeptide. APUD amine precursor uptake and decarboxylation.
INTRODUCTION
Pancreatic islet cell tumours are rare. They are often associated with syndromes characteristic of excess of individual peptide hormones, such as gastrin, insulin, glucagon and vasoactive intestinal peptide (VIP) 1-3. Amongst these tumours malignant pancreatic polypeptide (HPP) producing tumours are uncommon, and despite markedly elevated hormone levels may be asymptomatic4'5. They may thus present with advanced or metastatic disease.
We report a case of such a tumour, and review the management problems.
CASE HISTORY
The patient, a 32 year old male, presented with a three week history of right upper quadrant pain, diarrhoea, abdominal distension and flatulence. His Blood HPP was 17035 pmol/1 (normal < 300) and neurotensin 183 pmol/1 (normal < 100). The other GI hormones were within normal limits. Upper GI endoscopy and barium meal were normal.
Ultrasound and CT scanning showed a dilated pancreatic duct (2 cm in diameter) with a normally enhancing rim of pancreatic tissue. The ductal dilatation was maximal in the head of the pancreas. There was only slight if any dilatation of the extrahepatic biliary tree. A 4 cm diameter mass lay between the aorta, superior mesenteric vessels and the third part of the duodenum. Two small hypodense lesions were seen in the liver on CT but not on ultrasonography. Endoscopic retrograde cholangio-pancreatography failed to visualise the pancreatic duct but there was no abnormality of duodenum, papilla nor biliary tree.
The patient thus underwent a second laparotomy. Multiple nodules were found in each side of the liver, these were biopsied. No discrete mass was found in the area of the pancreas but there were dense adhesions from the previous surgery surrounding the head of pancreas. No other intraperitoneal tumour was identified. The pancreatic duct was needled and an on table pancreatogram performed ( Figure   2 ). This showed the duct to be dilated to approximately 2 cm, down to the ampulla of Vater. A side-to-side pancreatico-jejunostomy was thus formed. The patient recovered quickly from this operation with no residual pain. Histological examination of the liver biopsies confirmed the clinical impression of metastatic tumour, of similar appearance to the original endocrine primary (Figure 3 ). Fine needle aspiration cytology of the pancreas showed no evidence of recurrent carcinoma.
When last seen in the outpatient clinic, 46 months after the second operation (80 months after the first) the patient was well and pain free. Loose bowel actions occur about six times daily but there are no other residual symptoms and his weight is steady. The serum HPP was over 10000 pmol/1 and neurotensin over 1000 pmol/l. 
